82 related articles for article (PubMed ID: 24986569)
1. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer.
Wang YZ; Wu KP; Wu AB; Yang ZC; Li JM; Mo YL; Xu M; Wu B; Yang ZX
Tumour Biol; 2014 Oct; 35(10):9815-21. PubMed ID: 24986569
[TBL] [Abstract][Full Text] [Related]
2. The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer.
Li Y; Cai G; Yuan S; Jun Y; Li N; Wang L; Chen F; Ling R; Yun J
Am J Transl Res; 2015; 7(1):120-7. PubMed ID: 25755834
[TBL] [Abstract][Full Text] [Related]
3. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer.
Dong Y; Chen G; Gao M; Tian X
Gene; 2015 May; 563(1):29-34. PubMed ID: 25748728
[TBL] [Abstract][Full Text] [Related]
5. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Ager EI; Kozin SV; Kirkpatrick ND; Seano G; Kodack DP; Askoxylakis V; Huang Y; Goel S; Snuderl M; Muzikansky A; Finkelstein DM; Dransfield DT; Devy L; Boucher Y; Fukumura D; Jain RK
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25710962
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP, MMP14) in Eutopic and Ectopic Endometrium and in Serum and Endocervical Mucus of Endometriosis.
Maoga JB; Riaz MA; Mwaura AN; Mecha E; Omwandho COA; Scheiner-Bobis G; Meinhold-Heerlein I; Konrad L
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893104
[TBL] [Abstract][Full Text] [Related]
7. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
Zhao T; Li X; Li M; Jamil M; Zhang J
Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted roles of matrix metalloproteinases in lung cancer.
Wei C
Front Oncol; 2023; 13():1195426. PubMed ID: 37766868
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer.
Titmarsh HF; von Kriegsheim A; Wills JC; O'Connor RA; Dhaliwal K; Frame MC; Pattle SB; Dorward DA; Byron A; Akram AR
Front Oncol; 2023; 13():1194515. PubMed ID: 37397358
[TBL] [Abstract][Full Text] [Related]
10. MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells.
Pratt J; Haidara K; Annabi B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430705
[TBL] [Abstract][Full Text] [Related]
11. A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.
Gargiuli C; De Cecco L; Mariancini A; Iannò MF; Micali A; Mancinelli E; Boeri M; Sozzi G; Dugo M; Sensi M
Front Oncol; 2022; 12():911613. PubMed ID: 35928879
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and Quantitative Analysis of Tumor Cell Invasion Using Au Clusters.
Zhang X; Zheng Q; Wang Z; Xu C; Han H; Li A; Ma G; Li J; Lu C; Chen H; Zhang Z
Nanomaterials (Basel); 2021 Dec; 12(1):. PubMed ID: 35010094
[TBL] [Abstract][Full Text] [Related]
14. M2PP: a novel computational model for predicting drug-targeted pathogenic proteins.
Wang S; Li J; Wang Y
BMC Bioinformatics; 2022 Jan; 23(1):7. PubMed ID: 34983358
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.
Yan J; Wan D
J Clin Lab Anal; 2022 Feb; 36(2):e24140. PubMed ID: 34952984
[TBL] [Abstract][Full Text] [Related]
16. MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma.
Zhou Y; Liu H; Zheng W; Chen Q; Hu S; Pan Y; Bai Y; Zhang J; Shao C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638754
[TBL] [Abstract][Full Text] [Related]
17. The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis.
Ritchie S; Reed DA; Pereira BA; Timpson P
Fac Rev; 2021; 10():4. PubMed ID: 33659922
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-14 (MMP-14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation.
Chen N; Zhang G; Fu J; Wu Q
Thorac Cancer; 2020 Nov; 11(11):3168-3174. PubMed ID: 32930509
[TBL] [Abstract][Full Text] [Related]
19. Insufficient CD100 shedding contributes to suppression of CD8
Wang HM; Zhang XH; Ye LQ; Zhang K; Yang NN; Geng S; Chen J; Zhao SX; Yang KL; Fan FF
Immunology; 2020 Jun; 160(2):209-219. PubMed ID: 32149403
[TBL] [Abstract][Full Text] [Related]
20. Angiocrine endothelium: from physiology to cancer.
Pasquier J; Ghiabi P; Chouchane L; Razzouk K; Rafii S; Rafii A
J Transl Med; 2020 Feb; 18(1):52. PubMed ID: 32014047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
